QRD Pharma Q1 2025 Update

May 11, 2025

At QRD Pharma, we’re proud to have completed a productive first quarter and are excited to support the research efforts of both current and future clients throughout the remainder of this year and beyond.

As a science-driven contract research organization (CRO), QRD Pharma specializes in LC-MS-based bioanalytical services, supporting research from early discovery through to product launch. To learn more about our capabilities, reach out to us at [email protected].